Archives of Clinical Infectious Diseases

Published by: Kowsar

Is Hepatitis E a Vaccine Preventable Diseases?

Masoud Mardani 1 , *
Author Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: April 1, 2015, 10 (2); e28726
  • Published Online: April 22, 2015
  • Article Type: Editorial
  • Received: March 5, 2015
  • Accepted: March 15, 2015
  • DOI: 10.5812/archcid.10(2)2015.28726

To Cite: Mardani M. Is Hepatitis E a Vaccine Preventable Diseases?, Arch Clin Infect Dis. 2015 ; 10(2):e28726. doi: 10.5812/archcid.10(2)2015.28726.

Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Decard BF, Grimm A, Andelova M, Deman A, Banderet B, Garcia M, et al. Hepatitis-E virus associated neuralgic amyotrophy with sustained plexus brachialis swelling visualized by high-resolution ultrasound. J Neurol Sci. 2015; [DOI][PubMed]
  • 2. Tsarev SA, Binn LN, Gomatos PJ, Arthur RR, Monier MK, van Cuyck-Gandre H, et al. Phylogenetic analysis of hepatitis E virus isolates from Egypt. J Med Virol. 1999; 57(1): 68-74[PubMed]
  • 3. Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis. 2010; 16(1): 126-9[DOI][PubMed]
  • 4. Kmush B, Wierzba T, Krain L, Nelson K, Labrique AB. Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa. Semin Liver Dis. 2013; 33(1): 15-29[DOI][PubMed]
  • 5. Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015; 372(10): 914-22[DOI][PubMed]
  • 6. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012; 55(4): 988-97[DOI][PubMed]
  • 7. Gurley ES, Halder AK, Streatfield PK, Sazzad HM, Huda TM, Hossain MJ, et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am J Public Health. 2012; 102(12): 2248-54[DOI][PubMed]
  • 8. Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother. 2015; [DOI][PubMed]
  • 9. Shrestha MP, Scott RM, Joshi DM, Mammen MJ, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007; 356(9): 895-903[DOI][PubMed]
  • 10.
  • 11. Alavian SM, Fallahian F, Lankarani KB. Epidemiology of Hepatitis E in Iran and Pakistan. Hepat Mon. 2009; 9(1): 60-5
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments